F

Fink Family Office

2 employees

The Fink Family Office operates as a family investment office.

Investor insights

Sectors invested in

Biotechnology2

Medical2

Duchenne1

Pharmaceutical1

Biopharma1

Therapeutics1

Health Care1

Advanced Materials1

Nanotechnology1

Life Science1

Medical Device1

Electronics1

Neuroscience1

Chemical Engineering1

Robotics1

Industrial Automation1

hyperhomocysteinemia1

preclinical1

Huntington's disease1

rare disease1

Funding rounds participated in

$1.8M sweet spot round size

Most of their 4 investments are in rounds between $1.1M and $2.4M

Investor type

Family Investment Office

Basic info

Industry

venture capital and private equity principals

Sectors

Date founded

2018

Investments made

E

EnsiliTech raised $1.1M on January 17, 2023

Investors: QantX, Elbow Beach Capital, Science Angel Syndicate and Fink Family Office

Q

QV Bioelectronics raised $2.4M on January 10, 2023

Investors: Northern Gritstone, SOSV - The Accelerator VC, Elbow Beach Capital, Science Angel Syndicate and Fink Family Office

C

CheMastery Group Ltd raised undisclosed on November 13, 2022

Investors: Formic Ventures, Kadmos Capital Ltd, Undeterred Capital, HERMESA, Key Ventures, Dhyan ventures, Science Angel Syndicate, Elbow Beach Capital, Cur8 Capital and Fink Family Office

M

MitoRx Therapeutics raised undisclosed on April 25, 2022

Investors: Future Planet Capital, UK Innovation & Science Seed Fund, Wren Capital LLP, Longevitytech.fund, Science Angel Syndicate, Oxford Technology Management and Fink Family Office